Polymorphisms of nucleotide excision repair genes predict melanoma survival

Journal of Investigative Dermatology

Volumn 133, Issue 7, 2013, Pages 1813-1821

  Li, Chunying ^a,b   Yin, Ming ^a,b   Wang, Li E ^b   Amos, Christopher I ^b,c   Zhu, Dakai ^b,c   Lee, Jeffrey E ^b   Gershenwald, Jeffrey E ^b   Grimm, Elizabeth A ^b   Wei, Qingyi ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; EXCISION REPAIR CROSS COMPLEMENTING 1 GENE; EXCISION REPAIR CROSS COMPLEMENTING 3 GENE; EXCISION REPAIR CROSS COMPLEMENTING 4 GENE; EXCISION REPAIR CROSS COMPLEMENTING 5 GENE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; XERODERMA PIGMENTOSUM GROUP D GENE;

EID: 84879412932     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.498     Document Type: Article

References (23)

1. Amos CI, Wang LE, Lee JE et al. (2011) Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 20:5012-23
2. Balch CM, Gershenwald JE, Soong SJ et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-206
3. Buettner PG, Leiter U, Eigentler TK et al. (2005) Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 103:616-24
4. Chin L, Garraway LA, Fisher DE et al. (2006) Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20:2149-82
5. de Boer J, Hoeijmakers JH (1999) Cancer from the outside, aging from the inside: mouse models to study the consequences of defective nucleotide excision repair. Biochimie 81:127-37
6. DiFronzo LA, Gupta RK, Essner R et al. (2002) Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine. J Clin Oncol 20:3242-8 (Pubitemid 34831521)
7. Gershenwald JE, Ross MI (2011) Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med 364:1738-45
8. Houtsmuller AB, Rademakers S, Nigg AL et al. (1999) Action of DNA repair endonuclease ERCC1/XPF in living cells. Science 284:958-61 (Pubitemid 29288433)
9. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
10. Kauffmann A, Rosselli F, Lazar V et al. (2008) High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 27:565-73 (Pubitemid 351158908)
11. Kertat K, Rosdahl I, Sun XF et al. (2008) The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population. Oncol Rep 20:179-83
12. Li C, Hu Z, Liu Z et al. (2006) Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev 15:2526-32 (Pubitemid 46048316)
13. Liu D, O'Day SJ, Yang D et al. (2005) Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochem-otherapy: an exploratory study. Clin Cancer Res 11:1237-46 (Pubitemid 40175776)
14. Missura M, Buterin T, Hindges R et al. (2001) Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair. EMBO J 20:3554-64 (Pubitemid 32634362)
15. Sancar A (1995) DNA repair in humans. Annu Rev Genet 29:69-105 (Pubitemid 26005337)
16. Schrama D, Scherer D, Schneider M et al. (2011) ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma. J Invest Dermatol 131:1280-90
17. Shen M, Berndt SI, Rothman N et al. (2005) Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 116:768-73 (Pubitemid 41099708)
18. Sijbers AM, de Laat WL, Ariza RR et al. (1996) Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 86:811-22 (Pubitemid 26303449)
19. Spatz A, Batist G, Eggermont AM (2010) The biology behind prognostic factors of cutaneous melanoma. Curr Opin Oncol 22:163-8
20. Stern MC, Lin J, Figueroa JD et al. (2009) Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 69:6857-64
21. von Thaler AK, Kamenisch Y, Berneburg M (2010) The role of ultraviolet radiation in melanomagenesis. Exp Dermatol 19:81-8
22. Woods JE, Soule EH, Creagan ET (1983) Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 198:63-4 (Pubitemid 13059119)
23. Yokoi M, Masutani C, Maekawa T et al. (2000) The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J Biol Chem 275:9870-5 (Pubitemid 30185224)